ArticleInternational urology and nephrology2025
Contemporary kidney stone analysis composition among U.S. adults and children in a large reference laboratory setting.
Article in International urology and nephrology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Neutrophil Secretory Proteins Inhibit Calcium Oxalate Crystallisation and Crystal Growth, but Promote Crystal Aggregation.Immunology · 2026Article
- Unveiling potential natural promoters of calcium oxalate kidney stones in the urine via anion-exchange chromatography, crystal assays, and proteomics.Molecular and cellular biochemistry · 2026Article
- Lactobacillus acidophilus abolishes oxalate-mediated renal epithelial barrier disruption and calcium oxalate monohydrate crystal adhesion to renal epithelial cells.Cellular & molecular biology letters · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo provide updated population-level data on stone composition by characterizing changes in the prevalence of kidney stone composition by patient age, gender, and geographic location using data from a large tertiary stone analysis laboratory.
methodsThe [redacted for anonymity] receives kidney stone specimens for analysis by infrared spectroscopy. All stones submitted over a 12-month period (December 2022-November 2023) are included in this report. Stone characteristics were analyzed together with patient age, gender, and geographic location.
results85,273 stones were analyzed. The rate of stone submission did not vary significantly by month (p = 0.37). Stones were more commonly from the male (55.5%) versus female patients. However, women made up a greater proportion of stone submissions aged 12-50 (53.9%). Individuals < 30 years of age made up 7.3% of stone submissions and had a significantly higher incidence of calcium phosphate stones (p < 0.05). Rare drug or metabolite stone submissions (0.04%) included xanthine, guaifenesin, triamterene, atazanavir, and N4-acetyl-sulfamethoxazole.
conclusionsIn contrast to previous findings, no difference in the prevalence of various stone types was observed by month of year. This may reflect evolving climate patterns, and warrants continued attention. The gender gap between men and women for stone formation is seen to be closing, with women submitting the majority of stones from individuals less than 50 years old. Whether this trend will persist as these women age in coming decades will be an important area of future study of stone epidemiology.
Indexed as
Identifiers
40080334What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.